Company Overview and News

 
Days of 'boozy, boys’ culture not over, says top businesswoman

2018-09-06 theage.com.au
Women in banking have long had to deal with a “boozy, boys' culture" and there is a lot of work to be done in achieving gender equality, says leading businesswoman Ann Sherry, who joins a number of females speaking out against corporate culture.
NAUBF TPGTF NAB NASXF TPPTY TGR SYD TPM NABZY TSLLF SYDDF

 
Days of 'boozy, boys’ culture not over, says top businesswoman

2018-09-06 smh.com.au
Women in banking have long had to deal with a “boozy, boys' culture" and there is a lot of work to be done in achieving gender equality, says leading businesswoman Ann Sherry, who joins a number of females speaking out against corporate culture.
NAUBF TPGTF NAB NASXF TPPTY TGR SYD TPM NABZY TSLLF SYDDF

 
Tassal Group, Ltd. 2018 Q4 - Results - Earnings Call Slides

2018-08-24 seekingalpha
The following slide deck was published by Tassal Group, Ltd. in conjunction with their 2018 Q4 earnings call.
TGR TSLLF

 
'Shine the spotlight': Small companies risk gender-based diversity targets

2018-08-15 theage.com.au
The Australian Institute of Company Directors is considering setting gender-based targets for small to mid-cap companies, with a new report revealing that women account for just 15.8 per cent of board roles in ASX 201-500 companies.
TPGTF TPPTY TGR TPM TSLLF

 
'Shine the spotlight': Small companies risk gender-based diversity targets

2018-08-15 smh.com.au
The Australian Institute of Company Directors is considering setting gender-based targets for small to mid-cap companies, with a new report revealing that women account for just 15.8 per cent of board roles in ASX 201-500 companies.
TPGTF TPPTY TGR TPM TSLLF

 
Tassal Group avoids any loss or damage in recent Tasmania storms

2018-05-25 proactiveinvestors.com.au
Tassal Group Ltd (ASX:TGR) has confirmed that it had zero fish-loss following significant storm events in Tasmania recently.
TGR TSLLF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:TGR / TASSAL GROUP LIMITED on message board site Silicon Investor.

Netgear, Inc. (NTGR) Netgear, Inc. (NTGR) Netgear, Inc. (NTGR) TIGER INTERNATIONAL RESOURCES---------TGR TIGER INTERNATIONAL RESOURCES---------TGR TIGER INTERNATIONAL RESOURCES---------TGR
Integrity Inc (ITGR) Integrity Inc (ITGR) Integrity Inc (ITGR) ITGR- Integrity,Inc. Online Christian Music/Video Store ITGR- Integrity,Inc. Online Christian Music/Video Store ITGR- Integrity,Inc. Online Christian Music/Video Store
Netgraphe (WWW / mse) Netgraphe (WWW / mse) Netgraphe (WWW / mse) Integrity Incorporated (ITGR) Integrity Incorporated (ITGR) Integrity Incorporated (ITGR)
NetGravity [NETG] NetGravity [NETG] NetGravity [NETG] Telegroup Inc (TGRP) Telegroup Inc (TGRP) Telegroup Inc (TGRP)
Net Grocer or NetGrocer [NTGR] - upcoming IPO Net Grocer or NetGrocer [NTGR] - upcoming IPO Net Grocer or NetGrocer [NTGR] - upcoming IPO